Akademik Veri Yönetim Sistemi
Endocrine, cilt.82, sa.3, ss.622-630, 2023 (SCI-Expanded)
Purpose: This study aims to analyze the clinicopathological features, diagnostic steps, and therapeutic results of TSHomas and to reveal the effective factors on remission. Methods: The clinical, radiological, and pathological features and surgical and endocrinological results of 41 TSHoma cases followed between 2005 and 2022 were retrospectively analyzed. The factors affecting the surgical cure were investigated by comparing the groups with and without remission. Results: A total of 41 patients (23 male,18 female) were included in the study and the mean age was 42 (31.5–49). Palpitation and headache were the most common complaints. The time from the onset of symptoms to diagnosis was 8 (3–20) months. There were 8 patients with a preoperative clinical and biochemical diagnosis of TSH + GH co-secretion. In the TRH stimulation test, a blunted TSH response was obtained in 18 patients (90.0%). Complete suppression could not be obtained in any of the patients who underwent the T3 suppression test. The median maximum tumor diameter was 19.0 mm (6.8–41). There was microadenoma in 4 (9.8%) patients and macroadenoma in 37 patients (92.8%). Remission was achieved in 31 (75.6%) of 40 patients who underwent endoscopic transsphenoidal surgery (eTSS). The Ki-67 labeling index was 2% (1.00–4.00) in the entire patient group. Preoperative use of antithyroid drugs appears to be significantly associated with surgical cure. Conclusion: Diagnosis of TSHoma is still full of challenges and dynamic tests remain important. Recognition and good management of inappropriate TSH secretion states affect subsequent surgical outcomes.